InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Neumora Therapeutics, Inc.

NMRA Clue Score21
United States Fiscal year ends December CIK 0001885522 Results filed 14 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

44
Insider
Date
Role
Action
Shares
Price
Amount
ARCH Venture Partners X, LLC
27 Oct 2025
10% owner
Buy indirect
1,915,700
$2.61
$5.00M
ARCH Venture Partners XII, LLC
27 Oct 2025
10% owner
Buy indirect
1,915,700
$2.61
$5.00M
Kristina Burow
27 Oct 2025
Director
Buy indirect
1,915,700
$2.61
$5.00M
ARCH Venture Partners XII, LLC
14 Nov 2023
10% owner
Buy indirect
3,357
$11.98
$40.22K
Kristina Burow
14 Nov 2023
Director
Buy indirect
3,357
$11.98
$40.22K
ARCH Venture Partners XII, LLC
13 Nov 2023
10% owner
Buy indirect
31,653
$11.75
$371.92K
Kristina Burow
13 Nov 2023
Director
Buy indirect
31,653
$11.75
$371.92K
ARCH Venture Partners XII, LLC
10 Nov 2023
10% owner
Buy indirect
5,431
$11.75
$63.81K
ARCH Venture Partners XII, LLC
10 Nov 2023
10% owner
Buy indirect
11,844
$11.37
$134.67K
Kristina Burow
10 Nov 2023
Director
Buy indirect
5,431
$11.75
$63.81K
Kristina Burow
10 Nov 2023
Director
Buy indirect
11,844
$11.37
$134.67K
ARCH Venture Partners XII, LLC
9 Nov 2023
10% owner
Buy indirect
31,079
$10.53
$327.26K
Kristina Burow
9 Nov 2023
Director
Buy indirect
31,079
$10.53
$327.26K
ARCH Venture Partners XII, LLC
8 Nov 2023
10% owner
Buy indirect
23,124
$11.79
$272.63K
ARCH Venture Partners XII, LLC
8 Nov 2023
10% owner
Buy indirect
69,127
$10.78
$745.19K
Kristina Burow
8 Nov 2023
Director
Buy indirect
23,124
$11.79
$272.63K
Kristina Burow
8 Nov 2023
Director
Buy indirect
69,127
$10.78
$745.19K
ARCH Venture Partners XII, LLC
7 Nov 2023
10% owner
Buy indirect
30,192
$11.50
$347.21K
Kristina Burow
7 Nov 2023
Director
Buy indirect
30,192
$11.50
$347.21K
ARCH Venture Partners XII, LLC
6 Nov 2023
10% owner
Buy indirect
43,082
$11.55
$497.60K
Kristina Burow
6 Nov 2023
Director
Buy indirect
43,082
$11.55
$497.60K
ARCH Venture Partners XII, LLC
3 Nov 2023
10% owner
Buy indirect
22,420
$11.38
$255.14K
Kristina Burow
3 Nov 2023
Director
Buy indirect
22,420
$11.38
$255.14K
ARCH Venture Partners XII, LLC
29 Sep 2023
10% owner
Buy indirect
34,560
$13.98
$483.15K
Kristina Burow
29 Sep 2023
Director
Buy indirect
34,560
$13.98
$483.15K
ARCH Venture Partners XII, LLC
28 Sep 2023
10% owner
Buy indirect
25,110
$13.69
$343.76K
ARCH Venture Partners XII, LLC
28 Sep 2023
10% owner
Buy indirect
16,841
$13.06
$219.94K
Kristina Burow
28 Sep 2023
Director
Buy indirect
25,110
$13.69
$343.76K
Kristina Burow
28 Sep 2023
Director
Buy indirect
16,841
$13.06
$219.94K
ARCH Venture Partners XII, LLC
27 Sep 2023
10% owner
Buy indirect
24,504
$12.31
$301.64K
Kristina Burow
27 Sep 2023
Director
Buy indirect
24,504
$12.31
$301.64K
ARCH Venture Partners XII, LLC
26 Sep 2023
10% owner
Buy indirect
34,000
$11.73
$398.82K
Kristina Burow
26 Sep 2023
Director
Buy indirect
34,000
$11.73
$398.82K
Kristina Burow
25 Sep 2023
Director
Buy indirect
29,967
$11.65
$349.12K
Kristina Burow
25 Sep 2023
Director
Buy indirect
30,773
$10.80
$332.35K
ARCH Venture Partners XII, LLC
25 Sep 2023
10% owner
Buy indirect
29,967
$11.65
$349.12K
ARCH Venture Partners XII, LLC
25 Sep 2023
10% owner
Buy indirect
30,773
$10.80
$332.35K
Kristina Burow
22 Sep 2023
Director
Buy indirect
40,000
$11.14
$445.60K
ARCH Venture Partners XII, LLC
22 Sep 2023
10% owner
Buy indirect
40,000
$11.14
$445.60K
Amgen Inc
19 Sep 2023
10% owner
Buy
1,764,705
$17.00
$30.00M
Henry O Gosebruch
19 Sep 2023
President & CEO
Buy indirect
15,000
$12.62
$189.37K
ARCH Venture Partners X, LLC
19 Sep 2023
10% owner
Buy indirect
1,500,000
$17.00
$25.50M
ARCH Venture Partners X, LLC
19 Sep 2023
10% owner
Buy indirect
1,500,000
$17.00
$25.50M
Kristina Burow
19 Sep 2023
Director
Buy indirect
1,500,000
$17.00
$25.50M
Show all 76 transactions →

What was left out

Form 4 filings counted 101
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 13
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 97,521,043
History held since 18 Sep 2023